Vincent Ossipow is a Partner at Omega Funds where he invests in biotech, medtech, life science tools, and robotics. He backs companies from Seed, Series A, Series B, Series C, and start-up through later stage growth, and invests across Switzerland, Europe, North America, the Middle East, and Africa. He has invested in companies like Callio Therapeutics, Aerium Therapeutics, FoRx Therapeutics, and Andrew Alliance.
Before Omega Funds, he served as Chief Scientific Officer of Omega Alpha SPAC (Nasdaq: OMEG). Earlier roles include Partner Private Equity and Investment Manager at Sectoral Asset Management, Faculty Member at Université de Genève, Financial Analyst at Banque Pictet & Cie SA, and Postdoctoral Fellow at the National Cancer Institute (NCI). Vincent graduated from the University of Geneva and lives in Geneva, Switzerland.
Vincent Ossipow, Partner @ Omega. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Vincent Ossipow from Omega Funds. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Vincent
Map your path to Vincent instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Vincent
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.